Inventor · disambiguated record
Justin Kenkel
Also filed as: KENKEL JUSTIN · KENKEL JUSTIN A
5 granted patents·8 pending applications·8 citations·filing 2016–2025
72Inventor score
Top patents by PatentIndex Score
13 records- 0192US11110178B2Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Sep 7, 2021·3 cites·30 claims
- 0291US10675358B2Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2018·Granted Jun 9, 2020·5 cites·30 claims
- 0379US12325750B2Anti-Dectin-2 antibodies and methods of usingBOLT BIOTHERAPEUTICS INC·Filed 2023·Granted Jun 10, 2025·0 cites·29 claims
- 0475US2023111340A1Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2022·Application pending·0 cites
- 0574US11547761B1Antibody adjuvant conjugatesUNIV LELAND STANFORD JUNIOR·Filed 2021·Granted Jan 10, 2023·0 cites·91 claims
- 0673US11753474B2Anti-Dectin-2 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·0 cites·131 claims
- 0773US2025270329A1Anti-Dectin-2 AntibodiesBOLT BIOTHERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0851US2023069055A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0949US2023086603A1Anti-pd-l1 antibodiesBOLT BIOTHERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1046US2022226491A1Immunoconjugates Targeting PD-L1BOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1146US2022143012A1Macromolecule-Supported TLR AgonistsBOLT BIOTHERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1243US2020140556A1Methods and Compositions for Dectin-2 Stimulation and Cancer ImmunotherapyUNIV LELAND STANFORD JUNIOR·Filed 2018·Application pending·0 cites
- 1340US2019010236A1Methods and compositions for dectin-2 stimulation and cancer immunotherapyUNIV LELAND STANFORD JUNIOR·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →